In conclusion, TLR7 is a reliable clinical indicator for predicting patient prognosis, immunotherapy response, and potential drug targets, thus providing new perspectives on therapeutic approaches for lung adenocarcinoma. Here, TLR7 is linked to lung adenocarcinoma.